Genomic and Immune Profiling of a Patient With Triple-Negative Breast Cancer That Progressed During Neoadjuvant Chemotherapy Plus PD-L1 Blockade.

Casadevall, David; Li, Xiaotong; Powles, Ryan L; Wali, Vikram B; Buza, Natalia; Pelekanou, Vasiliki; Dhawan, Arjun; Foldi, Julia; Szekely, Borbala; Lopez-Giraldez, Francesc; Hatzis, Christos; Pusztai, Lajos

Casadevall, David; Li, Xiaotong; Powles, Ryan L; Wali, Vikram B; Buza, Natalia; Pelekanou, Vasiliki; Dhawan, Arjun; Foldi, Julia; Szekely, Borbala; Lopez-Giraldez, Francesc; Hatzis, Christos; Pusztai, Lajos.

Afiliación

Casadevall D; Yale School of Medicine, New Haven, CT.
Li X; Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.
Powles RL; Yale School of Medicine, New Haven, CT.
Wali VB; Yale School of Medicine, New Haven, CT.
Buza N; Yale School of Medicine, New Haven, CT.
Pelekanou V; Yale School of Medicine, New Haven, CT.
Dhawan A; Yale School of Medicine, New Haven, CT.
Foldi J; Yale School of Medicine, New Haven, CT.
Szekely B; Yale School of Medicine, New Haven, CT.
Lopez-Giraldez F; Yale School of Medicine, New Haven, CT.
Hatzis C; National Institute of Oncology, Budapest, Hungary.
Pusztai L; Yale Center for Genome Analysis, New Haven, CT.

JCO Precis Oncol ; 32019.

Article en En | MEDLINE | ID: mdl-32914041

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JCO Precis Oncol Año: 2019 Tipo del documento: Article